As the method used in the present study allows determining phosphorylation and/or expression of several targets simultaneously, it is applicable for combining or correlating STAT1 and STAT6 phosphorylation with other markers, thereby possibly creating markers that can be utilized in tailoring personalized treatment for patients with RA in the future. Here, STAT6 is linked to rheumatoid arthritis.